Latest Intelligence on Medical Devices and Diagnostics in Asia-Pacific

Published within

« | 1 | » »|

Type Product title / description Pub Price
Expert View
Expert View

APA 2010: unmet needs in major depressive disorder remain key

Key themes presented in the field of major depressive disorder at this year's American Psychiatric Association annual meeting included treatment-resistant depression, transcranial magnetic stimulation and adjunctive use of antipsychotics. While no new clinical trial data were presented, those that were provide an interesting insight into the strategies of a number of major pharmaceutical players.

Published By Datamonitor
10 Jun 2010
Expert View
Expert View

AstraZeneca and Boehringer Ingelheim steal limelight at European Society of Cardiology meeting

Well crafted, positive results for AstraZeneca's Brilinta and an unexpected coup for Boehringer Ingelheim's Pradaxa dominated the headlines following this year's European Society of Cardiology's Annual Meeting in Barcelona. Both announcements have a number of important implications for the wider cardiology market, from both therapeutic and commercial perspectives.

Published By Datamonitor
03 Sep 2009
Expert View
Expert View

ATS 2010: developments in IPF and cystic fibrosis

The FDA's recent refusal of Esbriet and the publication of new guidelines for the treatment of idiopathic pulmonary fibrosis drove considerable interest in this disease at the 2010 meeting of the American Thoracic Society. Furthermore, the approval of the first new inhaled antibiotic for cystic fibrosis in over a decade brought renewed focus on this rare but extremely debilitating disease.

Published By Datamonitor
04 Jun 2010
Expert View
Expert View

ATS 2010: shift in asthma guidelines highlights focus on personalized medicine

Datamonitor attended this year's meeting of the American Thoracic Society in New Orleans. The 2010 conference was defined not only by the latest clinical trial data, but by new guidelines and an emerging discussion of the role of personalized treatment. Conclusions were also presented from the ISAAC study, highlighting some surprising global prevalence trends.

Published By Datamonitor
04 Jun 2010
CommentWire
CommentWire

Medical devices: Japanese price cuts on the way

While prices of orthopedic devices in Japan are certainly higher than those in the US and Europe, the manufacturers claim that heavy costs make the high prices a necessity. The industry is eagerly awaiting the outcome of US/Japan trade negotiations - but if these fail to halt the cuts, orthopedic firms will certainly take a large hit.

Published By Datamonitor
28 Jan 2002
ResearchWire
ResearchWire

Mobile bearing knees: over 76,000 to be sold in Europe in 2005

Published By Datamonitor
22 May 2001
CommentWire
CommentWire

Stents: new findings could dramatically change the market

A study has suggested that the mortality risk posed by stent thrombosis is increased five-fold for STEMI patients receiving drug-eluting stents, compared to bare-metal stents. If proven, stent development is likely to move away from new drug-coated stents allowing smaller companies a chance to compete with leading players such as Boston Scientific and Johnson & Johnson.

Published By Datamonitor
06 Sep 2007

« | 1 | » »|

No help is available.